138 related articles for article (PubMed ID: 1524331)
1. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
Deray G; Benhmida M; Le Hoang P; Maksud P; Aupetit B; Baumelou A; Jacobs C
Ann Intern Med; 1992 Oct; 117(7):578-83. PubMed ID: 1524331
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine dose adjustment using levels obtained six hours after the morning dose: effect on side effects in patients with autoimmune diseases.
Cantarovich M; Deschênes J
Am J Nephrol; 1997; 17(5):450-7. PubMed ID: 9382165
[TBL] [Abstract][Full Text] [Related]
3. Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
Isnard Bagnis C; Tezenas du Montcel S; Beaufils H; Jouanneau C; Jaudon MC; Maksud P; Mallet A; LeHoang P; Deray G
J Am Soc Nephrol; 2002 Dec; 13(12):2962-8. PubMed ID: 12444215
[TBL] [Abstract][Full Text] [Related]
4. Renal outcome after ciclosporin-induced nephrotoxicity.
Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
Feutren G; Mihatsch MJ
N Engl J Med; 1992 Jun; 326(25):1654-60. PubMed ID: 1588978
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
Rocha G; Deschênes J; Cantarovich M
Ophthalmology; 1997 Feb; 104(2):245-51. PubMed ID: 9052628
[TBL] [Abstract][Full Text] [Related]
7. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
Palestine AG; Austin HA; Nussenblatt RB
Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
[No Abstract] [Full Text] [Related]
9. Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.
Han F; Wu J; Huang H; Zhang X; He Q; Wang Y; Wang S; Wang H; Chen J
Exp Clin Transplant; 2011 Feb; 9(1):42-9. PubMed ID: 21605022
[TBL] [Abstract][Full Text] [Related]
10. Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine.
Ruggenenti P; Perico N; Amuchastegui CS; Ferrazzi P; Mamprin F; Remuzzi G
Am J Kidney Dis; 1994 Oct; 24(4):549-53. PubMed ID: 7942808
[TBL] [Abstract][Full Text] [Related]
11. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders.
Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ
Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963
[TBL] [Abstract][Full Text] [Related]
12. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
13. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
Pei Y; Scholey JW; Katz A; Schachter R; Murphy GF; Cattran D
Am J Kidney Dis; 1994 Apr; 23(4):528-36. PubMed ID: 8154488
[TBL] [Abstract][Full Text] [Related]
14. Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis.
de Smet MD; Rubin BI; Whitcup SM; Lopez JS; Austin HA; Nussenblatt RB
Am J Ophthalmol; 1992 Jun; 113(6):687-90. PubMed ID: 1598960
[TBL] [Abstract][Full Text] [Related]
15. Renal function and histopathologic changes in children after liver transplantation.
Laine J; Krogerus L; Fyhrquist F; Jalanko H; Rönnholm K; Holmberg C
J Pediatr; 1994 Dec; 125(6 Pt 1):863-9. PubMed ID: 7996357
[TBL] [Abstract][Full Text] [Related]
16. Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
Palestine AG; Austin HA; Balow JE; Antonovych TT; Sabnis SG; Preuss HG; Nussenblatt RB
N Engl J Med; 1986 May; 314(20):1293-8. PubMed ID: 3702930
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.
Pons JA; Ramírez P; Revilla-Nuin B; Pascual D; Baroja-Mazo A; Robles R; Sanchez-Bueno F; Martinez L; Parrilla P
Clin Transplant; 2009; 23(3):329-36. PubMed ID: 19210687
[TBL] [Abstract][Full Text] [Related]
18. Side effects of systemic cyclosporine in patients not undergoing transplantation.
Palestine AG; Nussenblatt RB; Chan CC
Am J Med; 1984 Oct; 77(4):652-6. PubMed ID: 6486141
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
Zawiasa A; Nowicki M
Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
